← Back to Search

Endocrine Disruptor

bisphenol A for Diabetes

N/A

Waitlist Available

Led By Todd Hagobian, PhD

Research Sponsored by California Polytechnic State University-San Luis Obispo

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be between 18 and 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline and 4 days

Awards & highlights

Study Summary

This trial will study the effects of BPA on insulin sensitivity and glucose suppression.

Eligible Conditions

Diabetes
Insulin Sensitivity
Microtia

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline and 4 days

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline and 4 days

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline and 4 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in rate of glucose appearance

Change in rate of glucose disposal

Secondary outcome measures

Change in concentration of 17-beta estradiol

Change in concentration of adiponectin

Change in concentration of c-peptide

+5 more

Trial Design

2Treatment groups

Experimental Treatment

Placebo Group

Group I: Diet plus bisphenol AExperimental Treatment1 Intervention

Participants will receive a 4-day diet plus bisphenol A at 50 ug/kg body weight.

Group II: PlaceboPlacebo Group1 Intervention

Participants will receive a 4-day diet plus no bisphenol A.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

American Diabetes AssociationOTHER

137 Previous Clinical Trials

99,462 Total Patients Enrolled

17 Trials studying Diabetes

1,867 Patients Enrolled for Diabetes

California Polytechnic State University-San Luis ObispoLead Sponsor

29 Previous Clinical Trials

3,247 Total Patients Enrolled

Hannah Brunner-GaydosStudy DirectorCalifornia Polytechnic State University-San Luis Obispo

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this research include geriatric participants?

"The requirements for entry into this medical trial specifies that participants should be between the age of majority and 50 years old."

Answered by AI

How many participants are being monitored in this trial?

"Affirmative. Based on published information in clinicaltrials.gov, this study is currently enrolling candidates and was initially posted to the website back on January 1st 2019. It has been updated as recently as January 25th 2021, with 40 enrollees being sought from one site."

Answered by AI

Is this study currently enrolling new participants?

"Per the clinicaltrials.gov data, this study is currently recruiting patients and was initially published on January 1st 2019 with a recent edit to its page dated January 25th 2021."

Answered by AI

What effects are researchers expecting to observe as a result of this investigation?

"This trial has a baseline and 4 day duration with the primary goal of assessing changes in glucose disposal. Secondary objectives include monitoring changes in fasting blood sample concentrations for glucose, 17-beta estradiol, and c-peptide."

Answered by AI

Could I be a potential participant in this experiment?

"This medical experiment requires 40 volunteers aged 18 to 50 who suffer from microtia. Additionally, these participants must not be dieting; they need to have a BMI between 18.5 and 24.9 kg/m2, no chronic illnesses or metabolic issues, sedentary for ≤3 hours per week of aerobic activity with weight-stability within the last 6 months, non-smoking status etcetera."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Bisphenol A and Muscle Insulin Sensitivity

Todd Hagobian 2019. "Bisphenol A and Muscle Insulin Sensitivity". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03771066.